Valiant Laboratories

Valiant Laboratories Inventory Turnover

The Inventory Turnover Ratio of Valiant Laboratories (VALIANTLAB.NS) as of Nov 4, 2026 is 4.63. In the previous year, Inventory Turnover Ratio was 29.23 — a change of -84.17% (lower).

Inventory Turnover

4.63

YoY

-84.17%

Last updated:

Inventory Turnover Ratio of Valiant Laboratories is 2026 4.63 . Inventory Turnover Ratio of Valiant Laboratories was 2025 29.23 . It decreases by -84.17% lower compared to the previous year.

The Valiant Laboratories Inventory Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory Turnover
Date
Inventory Turnover
Jan 1, 2021
20.41 INR
Jan 1, 2022
15.14 INR
Jan 1, 2023
21.83 INR
Jan 1, 2024
17.02 INR
Jan 1, 2025
29.23 INR
Jan 1, 2026
4.63 INR
The Valiant Laboratories Inventory Turnover history
YEARInventory TurnoverYoY
4.63-84.17%
29.23+71.73%
17.02-22.03%
21.83+44.23%
15.14-25.86%
20.41—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Laboratories Stock analysis

What does Valiant Laboratories do? Valiant Laboratories Ltd manufactures paracetamol API/bulk drug for pharmaceutical applications, targeting medical conditions such as headache, muscle ache, arthritis, back ache, toothache, cold, and fever. The company operates a single manufacturing facility at Tarapur industrial estate, approximately 150 km from Nhava Sheva Port (JNPT), producing specialty chemicals and pharma intermediates for domestic and international markets. Its subsidiary, VALIANT ADVANCED SCIENCES PRIVATE LIMITED, supports the company's operations in the pharmaceutical sector. The firm's primary revenue comes from selling paracetamol API and specialty chemicals to pharmaceutical companies and distributors globally. Manufacturing focuses on high-demand applications like pain relief and fever treatment, with products distributed across India and abroad. The company leverages its Tarapur facility's proximity to Nhava Sheva Port for efficient export logistics. Valiant Laboratories Ltd serves the pharmaceutical industry by supplying essential active ingredients, particularly paracetamol, which is widely used in over-the-counter medications. The company's manufacturing capabilities for specialty chemicals and pharma intermediates cater to both domestic and international clients seeking reliable API sources. Its single-location production model ensures focused resource allocation for consistent output quality. Valiant Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Laboratories stock

Inventory Turnover Ratio of Valiant Laboratories is 4.63 in 2026.

Inventory Turnover Ratio of Valiant Laboratories changed from 29.23 to 4.63, representing a -84.17% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Turnover Ratio Valiant Laboratories since 2006 – with annual values, charts, and detailed analysis.

Inventory turnover measures how many times inventory is sold and replaced during a period. Higher turnover indicates efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory Turnover Ratio's Valiant Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Valiant Laboratories

All Key Metrics — Valiant Laboratories